ACI has been accepted as a Founding Member of the Community of Global Growth Companies by the World Economic Forum which is the most prestigious business networking organisation, this membership is a matter of pride for us.
ACI Limited is a leading manufacturer of pharmaceutical finished formulations and modified release ready to fill bulk pellets in Bangladesh. ACI manufactures a wide range of dosage forms including tablet, capsule, dry syrup, powder, cream, ointment, ophthalmic preparations, Metered Dose Inhalers (MDI) and small volume parenterals in several world-class manufacturing plants. ACI also manufactures ready- tofill bulk pellets of anti-inflammatory, antiulcerant, cardiovascular, respiratory and neutraceuticals. ACI was transformed from ICI Plc, a UK based multinational company in 1992 when ICI Plc sold its stakes and was renamed as Advanced Chemical Industries Ltd. The multinational heritage of ICI is embodied in the culture of ACI. ACI Limited is a public limited company having stocks traded in all the bourses of Bangladesh. Since its inception in 1992, ACI has earned the image of a quality house of pharmaceuticals and achieved impressive growth. Quality affordable products manufactured in world class manufacturing plants, diversified product portfolio, fast new product development capability, own R & D facilities to develop both formulations and ready to fill bulk pellets, innovative and market focused marketing, professional management and experience in international markets are drivers of ACI's growth. Today ACI is the fastest growing major pharmaceutical company in Bangladesh. ACI's business today is diverse in its product line and the breadth of its market participation. ACI has 224 products in 481 dosage forms covering almost all the therapeutic areas. This diversification will ensure that ACI will maintain its track record of strong growth and stability.
ACI is the first company in Bangladesh to obtain certification of ISO 9001 Quality Management System in 1995. ACI is also the first Company in Bangladesh to get certification of ISO 14001 Environmental Management System in 2000. ACI employees are proud of their work culture, business ethics and environmental consciousness. ACI's finished dosages have an enviable track record in the domestic pharmaceutical market. Some of them such as Acical, Floxabid, Fluclox, Revital, Xantid and Xeldrin are among the top brands in Bangladesh. ACI is the market leader in household hygiene market and its Savlon/ Septex brand is a household name. All this has been possible because of ACI's innovative product-market strategies. ACI's finished dosages are exported to a number of countries in Asia, Africa and Central America. ACI is well set to expand its presence and touch more lives across the world. ACI is a future driven company. The company is poised to grab the opportunities created and fight the challenges arising in the marketplace. To take advantage of the opportunities, ACI is introducing Dry Powder Inhalers (DPI), Human Insulins and Hormones in near future. ACI products are manufactured in five manufacturing units in Narayanganj, 20 kilometers southeast of capital Dhaka, with strict adherence to the current Good Manufacturing Practice (cGMP) of WHO. ACI has partnered with some of world's leading pharmaceutical companies. ACI has in-licensing agreement with French pharmaceutical major Servier. ACI currently manufactures world leading brands of Servier like Daflon, Diamicron, Duxil and Nutrilix SR in its plants. Contract manufacturing is another avenue ACI is open to discuss. Advanced manufacturing technology, quality products and low conversion cost made Bangladesh a unique place for contract manufacturing of pharmaceutical products. Today ACI contract manufactures a number of ophthalmic preparations of world's leading pharmaceutical company Novartis. ACI also has partnerships with world renowned companies AstraZeneca and UCB. ACI's...
Please join StudyMode to read the full document